INVA Return on Tangible Equity | INNOVIVA, INC.

INNOVIVA, INC. (INVA) Return on Tangible Equity

2026-06-30: Return Tang Equity 30.28%.
2026-03-31: Return Tang Equity 39.15%.
2025-12-31: Return Tang Equity 24.22%.
2025-09-30: Return Tang Equity 13.31%.

Complete source-backed return tang equity history.

Available history: 2012-03-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	30.28%
2026-03-31	39.15%
2025-12-31	24.22%
2025-09-30	13.31%
2025-06-30	5.84%
2025-03-31	-10.06%
2024-12-31	3.67%
2024-09-30	10.50%
2024-06-30	23.76%
2024-03-31	27.89%
2023-12-31	28.92%
2023-09-30	8.69%
2023-06-30	39.07%
2023-03-31	43.62%
2022-12-31	43.74%
2022-09-30	56.66%
2022-06-30	59.76%
2022-03-31	85.94%
2021-12-31	181.61%
2021-09-30	208.30%
2021-06-30	285.42%
2021-03-31	76.76%
2020-12-31	89.50%
2020-09-30	101.00%
2020-06-30	115.02%
2020-03-31	136.94%
2019-12-31	187.53%
2019-09-30	726.14%
2019-06-30	2696.43%
2019-03-31	-1777.77%
2018-12-31	-699.81%
2018-09-30	-60.57%
2018-06-30	-45.86%
2018-03-31	-34.75%
2017-12-31	-29.54%
2017-09-30	-23.29%
2017-06-30	-16.11%
2017-03-31	-6.61%
2016-12-31	-18.39%
2016-03-31	-9.29%
2015-03-31	-5.56%
2012-03-31	262.21%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	26.31%
2024-12-31	4.26%
2023-12-31	33.73%
2022-12-31	53.10%
2021-12-31	126.97%
2020-12-31	70.69%
2019-12-31	100.93%
2018-12-31	1385.56%
2017-12-31	-36.57%
2016-12-31	-12.47%
2015-12-31	4.02%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
ArriVent BioPharma, Inc. (AVBP)	United States	$1.485B	-10.25
Ultragenyx Pharmaceutical Inc. (RARE)	United States	$1.456B	-5.62
OMEROS CORP (OMER)	United States	$1.456B	5.50
ANAPTYSBIO, INC (ANAB)	United States	$1.546B	-60.20
Kailera Therapeutics, Inc. (KLRA)	United States	$1.552B
Syndax Pharmaceuticals Inc (SNDX)	United States	$1.606B	-8.82
Oric Pharmaceuticals, Inc. (ORIC)	United States	$1.367B	-8.00
Rapport Therapeutics, Inc. (RAPP)	United States	$1.623B	-14.56
Stoke Therapeutics, Inc. (STOK)	United States	$1.630B	-9.82
Xeris Biopharma Holdings, Inc. (XERS)	United States	$1.632B	-80.10